23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Biogen Inc. › 2025-2026

Biogen Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Biogen Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 12Ballot items
  • 873Asset managers, any item
  • 11,063Fund votes
  • June 9, 2026Meeting date

Results at a glance

Meeting of June 9, 2026: 12 items on Biogen Inc.’s Form 8-K, filed June 10, 2026: 2 approved · 10 passed (calculated).

Dissent

Significant dissent: 1 director (23.2% against).

Notable dissent: 5 directors (16.5%, 16.2%, 15.4%, 15.4%, 14.7% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Biogen Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Biogen Inc.

These tallies are Biogen Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Biogen Inc. — official shareholder meeting results, meeting held June 9, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Maria C. Freire 103,033,12118,790,23784,064 --9,359,127 85%Passed (calculated)—
Elect Director: William A. Hawkins 102,135,20419,683,09889,120 --9,359,127 84%Passed (calculated)—
Elect Director: Susan K. Langer 103,931,40617,886,54489,472 --9,359,127 85%Passed (calculated)—
Elect Director: Jesus B. Mantas 101,698,18720,117,07792,158 --9,359,127 83%Passed (calculated)—
Elect Director: Lloyd Minor 121,220,738594,00092,684 --9,359,127 99.5%Passed (calculated)—
Elect Director: Menelas Pangalos 121,130,060682,98394,379 --9,359,127 99.4%Passed (calculated)—
Elect Director: Monish Patolawala 120,796,2491,016,05795,116 --9,359,127 99.2%Passed (calculated)—
Elect Director: Eric K. Rowinsky 93,569,68528,216,589121,148 --9,359,127 77%Passed (calculated)—
Elect Director: Stephen A. Sherwin 103,025,92318,788,27293,227 --9,359,127 85%Passed (calculated)—
Elect Director: Christopher A. Viehbacher 121,127,966688,05191,405 --9,359,127 99.4%Passed (calculated)—
2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast 124,551,8876,627,08687,576 ---- 95%Approved—
3. Advisory vote on executive compensation, with the votes cast 114,184,8167,454,737267,869 --9,359,127 94%Approved—

Source: Biogen Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.

How asset managers voted at the Biogen Inc. 2025-2026 meeting

873 asset managers disclosed a vote on at least one Biogen Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Christopher A. Viehbacher

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 121,127,966AGAINST: 688,051

Prior year: 99.2% for (June 17, 2025 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher

Biogen Inc.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 121,127,966 for, 688,051 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 67,229,412 for, 44,093 against, 28,664 abstained, 175 not voted.

FOR
FOR: 67,229,412AGAINST: 44,093ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,906,04730,740 10For
Fidelity14,004,6460 00For
BlackRock6,103,3172,444 00For
State Street2,210,7393,679 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Eric K. Rowinsky

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST
FOR: 93,569,685AGAINST: 28,216,589

Prior year: 78.6% for (June 17, 2025 meeting) ▼ 1.8 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky

Biogen Inc.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 93,569,685 for, 28,216,589 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 51,464,101 for, 15,780,674 against, 57,392 abstained, 175 not voted.

FORAGAINST
FOR: 51,464,101AGAINST: 15,780,674ABSTAIN: 57,392NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,643,53312,293,253 10Mixed
Fidelity13,971,24633,400 00For
BlackRock6,104,1971,564 00For
State Street2,214,37840 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,069385 00For
T. Rowe Price663,310388,836 00Mixed
John Hancock885,97021,112 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS0529,991 00Against
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National229,22247,638 00Mixed
Bridge Builder Trust84,368188,122 00Mixed
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Jesus B. Mantas

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 101,698,187AGAINST: 20,117,077

Prior year: 80.7% for (June 17, 2025 meeting) ▲ 2.8 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas

Biogen Inc.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 101,698,187 for, 20,117,077 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 52,574,827 for, 14,722,676 against, 28,664 abstained, 175 not voted.

FORAGAINST
FOR: 52,574,827AGAINST: 14,722,676ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,632,72212,304,063 10Mixed
Fidelity13,971,24633,400 00For
BlackRock6,103,3172,444 00For
State Street2,210,7393,679 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price663,310388,836 00Mixed
John Hancock885,97021,112 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,760100 00For
Bridge Builder Trust203,96868,522 00Mixed
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
HUSSMAN INVESTMENT TRUST164,0000 00For
Transamerica148,1700 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Lloyd Minor

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 9 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 121,220,738AGAINST: 594,000

Prior year: 99.4% for (June 17, 2025 meeting) ▲ 0.1 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor

Biogen Inc.’s own tally for this item (“Elect Director: Lloyd Minor”): 121,220,738 for, 594,000 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 67,269,688 for, 3,816 against, 28,664 abstained, 175 not voted.

FOR
FOR: 67,269,688AGAINST: 3,816ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,936,77511 10For
Fidelity14,004,6460 00For
BlackRock6,105,7610 00For
State Street2,214,4180 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Maria C. Freire

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 103,033,121AGAINST: 18,790,237

Prior year: 83.0% for (June 17, 2025 meeting) ▲ 1.6 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire

Biogen Inc.’s own tally for this item (“Elect Director: Maria C. Freire”): 103,033,121 for, 18,790,237 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 52,974,894 for, 14,322,611 against, 28,664 abstained, 175 not voted.

FORAGAINST
FOR: 52,974,894AGAINST: 14,322,611ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,632,74012,304,047 10Mixed
Fidelity14,004,6460 00For
BlackRock6,103,3172,444 00For
State Street2,210,7393,679 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
HUSSMAN INVESTMENT TRUST164,0000 00For
Transamerica148,1700 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Menelas Pangalos

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 121,130,060AGAINST: 682,983

Prior year: 99.4% for (June 17, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos

Biogen Inc.’s own tally for this item (“Elect Director: Menelas Pangalos”): 121,130,060 for, 682,983 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 67,268,597 for, 4,907 against, 28,664 abstained, 175 not voted.

FOR
FOR: 67,268,597AGAINST: 4,907ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,936,77313 10For
Fidelity14,004,6460 00For
BlackRock6,105,7610 00For
State Street2,214,4180 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Monish Patolawala

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 120,796,249AGAINST: 1,016,057

Prior year: 99.5% for (June 17, 2025 meeting) ▼ 0.4 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala

Biogen Inc.’s own tally for this item (“Elect Director: Monish Patolawala”): 120,796,249 for, 1,016,057 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 67,269,682 for, 3,821 against, 28,664 abstained, 175 not voted.

FOR
FOR: 67,269,682AGAINST: 3,821ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,936,76916 10For
Fidelity14,004,6460 00For
BlackRock6,105,7610 00For
State Street2,214,4180 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Stephen A. Sherwin

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 103,025,923AGAINST: 18,788,272

Prior year: 82.7% for (June 17, 2025 meeting) ▲ 1.8 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin

Biogen Inc.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 103,025,923 for, 18,788,272 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 53,132,648 for, 14,140,856 against, 28,664 abstained, 175 not voted.

FORAGAINST
FOR: 53,132,648AGAINST: 14,140,856ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,663,46112,273,325 10Mixed
Fidelity14,004,6460 00For
BlackRock6,105,7610 00For
State Street2,214,37840 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
HUSSMAN INVESTMENT TRUST140,0000 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: Susan K. Langer

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 103,931,406AGAINST: 17,886,544

Prior year: 83.0% for (June 17, 2025 meeting) ▲ 2.3 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer

Biogen Inc.’s own tally for this item (“Elect Director: Susan K. Langer”): 103,931,406 for, 17,886,544 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 52,333,933 for, 14,963,571 against, 28,664 abstained, 175 not voted.

FORAGAINST
FOR: 52,333,933AGAINST: 14,963,571ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,663,47412,273,312 10Mixed
Fidelity13,971,24633,400 00For
BlackRock6,105,7610 00For
State Street2,214,4180 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price663,310388,836 00Mixed
John Hancock885,97021,112 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,760100 00For
Bridge Builder Trust203,96868,522 00Mixed
JPMorgan0263,339 00Against
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
HUSSMAN INVESTMENT TRUST164,0000 00For
Transamerica148,1700 00For
Equitable105,66216,810 00Mixed
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Elect Director: William A. Hawkins

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 8 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST
FOR: 102,135,204AGAINST: 19,683,098

Prior year: 82.9% for (June 17, 2025 meeting) ▲ 0.9 pts

Details: description as filed, official tally, votes by 145 asset managers

Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins

Biogen Inc.’s own tally for this item (“Elect Director: William A. Hawkins”): 102,135,204 for, 19,683,098 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 145 asset managers below reported 52,459,391 for, 14,838,114 against, 28,664 abstained, 175 not voted.

FORAGAINST
FOR: 52,459,391AGAINST: 14,838,114ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard18,632,71412,304,073 10Mixed
Fidelity14,004,6460 00For
BlackRock6,103,3172,444 00For
State Street2,210,7393,679 00For
PRIMECAP Odyssey Funds01,861,140 00Against
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS0529,991 00Against
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National229,32247,538 00Mixed
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
HUSSMAN INVESTMENT TRUST164,0000 00For
Transamerica148,1700 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For

Showing the 25 largest of 145 asset managers. All 145 are in the interactive database (link above).

Advisory vote on executive compensation, with the votes cast

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 114,184,816AGAINST: 7,454,737

Prior year: 67.9% for (June 17, 2025 meeting) ▲ 26.0 pts

Details: description as filed, official tally, votes by 829 asset managers

Description as filed by funds: Say on Pay - To hold an advisory vote on executive compensation.

Biogen Inc.’s own tally for this item (“3. The advisory vote on executive compensation, with the votes cast”): 114,184,816 for, 7,454,737 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Biogen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (31 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “14A Executive Compensation” (16 managers, 69,871 for, 20 abstained, 1,501 not voted).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 136 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,936,650133 40For
Fidelity14,004,6460 00For
BlackRock6,105,7610 00For
State Street2,214,4180 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For
Six Circles Trust113,7050 00For

Fund voting reports, all 136 managers: 66,840,609 for, 151,251 against, 32,472 abstained, 176 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 727 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
PRIMECAP MANAGEMENT CO/CA/14,700,7770 00For
Fidelity12,487,008318,602 00For
BlackRock7,169,141430 00For
State Street4,819,14212,821 00For
GEODE CAPITAL MANAGEMENT, LLC4,377,4940 00For
Wellington3,091,3830 00For
T. Rowe Price2,201,3410 00For
Invesco1,662,4350 00For
Vanguard1,523,3200 00For
Northern Trust1,251,0340 00For
Amundi01,210,058 00Against
Boston Partners1,149,1470 00For
Charles Schwab1,137,7680 00For
AQR946,3010 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC929,3610 00For
Robeco Institutional Asset Management B.V.874,0360 00For
UBS819,0980 00For
Legal & General Investment Management Ltd14,300780,951 00Against
PICTET ASSET MANAGEMENT SA781,2070 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/770,2230 00For
FRED ALGER MANAGEMENT, LLC770,0500 00For
MELLON INVESTMENTS Corp745,3240 00For
Goldman Sachs590,1340 00For
Legal & General Investment Management America Inc0553,563 00Against
Artemis Investment Management LLP545,2460 00For

Institutional-manager reports, all 727 managers: 75,435,952 for, 5,541,153 against, 145,819 abstained, 21,257 not voted. Showing the 25 largest; every one is in the interactive database (link above).

The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%
FOR: 124,551,887AGAINST: 6,627,086

Prior year: 95.3% for (June 17, 2025 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 142 asset managers

Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.

Biogen Inc.’s own tally for this item (“2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast”): 124,551,887 for, 6,627,086 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Biogen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 142 asset managers below reported 67,049,550 for, 24,895 against, 28,664 abstained, 175 not voted.

FOR
FOR: 67,049,550AGAINST: 24,895ABSTAIN: 28,664NOT VOTED: 175
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at Biogen Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard30,916,91219,877 10For
Fidelity14,004,6460 00For
BlackRock6,104,943818 00For
State Street2,214,37840 00For
PRIMECAP Odyssey Funds1,861,1400 00For
Invesco1,438,8280 00For
Charles Schwab1,088,4550 00For
T. Rowe Price1,052,1460 00For
John Hancock907,0820 00For
Pacer Funds Trust655,6280 00For
First Trust632,9670 00For
MFS529,9910 00For
Dimensional430,4610 00For
TIAA313,4280 00For
ALGER INSTITUTIONAL FUNDS299,3530 00For
Jackson National276,8600 00For
Bridge Builder Trust272,4900 00For
JPMorgan263,3390 00For
Victory Capital258,0730 00For
Advisor Managed Portfolios230,0000 00For
MASTER INVESTMENT PORTFOLIO228,3130 00For
Transamerica148,1700 00For
Equitable122,4720 00For
ALGER FUNDS120,3830 00For
Six Circles Trust113,7050 00For

Showing the 25 largest of 142 asset managers. All 142 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of June 17, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest Biogen Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 146,800,000 shares outstanding at the time of that meeting.

Fund voting reports: top Biogen Inc. shareholders by shares voted on “Say on Pay - To hold an advisory vote on executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 21.07%
2Fidelity 9.54%
3BlackRock 4.16%
4State Street 1.51%
5PRIMECAP Odyssey Funds 1.27%
6Invesco 0.98%
7Charles Schwab 0.74%
8T. Rowe Price 0.72%
9John Hancock 0.62%
10Pacer Funds Trust 0.45%
Institutional-manager reports: top Biogen Inc. shareholders by shares voted on “Say on Pay - To hold an advisory vote on executive compensation.”, 2025-2026
#Asset manager % of shares outstanding
1PRIMECAP MANAGEMENT CO/CA/ 10.01%
2Fidelity 8.72%
3BlackRock 4.88%
4State Street 3.29%
5GEODE CAPITAL MANAGEMENT, LLC 2.98%
6Wellington 2.11%
7T. Rowe Price 1.50%
8Invesco 1.13%
9Vanguard 1.04%
10Northern Trust 0.85%

Reported Biogen Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Biogen Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock15,974,601 10.88%Form 13F, quarter ended March 31, 2026
FMR (Fidelity)12,807,541 8.72%Form 13F, quarter ended March 31, 2026
State Street7,167,922 4.88%Form 13F, quarter ended March 31, 2026
Wellington Management2,961,641 2.02%Form 13F, quarter ended March 31, 2026
Morgan Stanley2,325,013 1.58%Form 13F, quarter ended March 31, 2026
JPMorgan Chase2,016,009 1.37%Form 13F, quarter ended March 31, 2026
Invesco1,745,255 1.19%Form 13F, quarter ended March 31, 2026

Percentages above are of 146,800,000 shares outstanding, as reported by Biogen Inc. on its Form 10-K dated December 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Biogen Inc.'s shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 873 asset managers reported votes on at least one of its 12 ballot items in their SEC Form N-PX filings, covering 11,063 separate fund positions. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — Biogen Inc.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Biogen Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Biogen Inc.’s 10-K dated December 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Biogen Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Biogen (BIIB) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/biogen-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.